Implandata Wins Medica Innovation World Cup – 1st Place of 300 Digital Health Ventures

Implandata Ophthalmic Products was awarded 1st place at the Healthcare Innovation World Cup at MEDICA, the world’s largest medical trade fair. With 300 healthtech companies from 60 countries, Implandata and its disruptive Eyemate system were recognized by the jury as the top digital health solution based on the level of innovation, go-to-market-approach, commercial potential and sustainability.

“The Implandata team is very excited and proud to win this prestigious award. It confirms the high degree of innovation of our Eyemate system, and the huge market opportunity it addresses," said Max Ostermeier, CEO and founder of the company.

Dominick Arena, Chairman of the company, says: “Implandata is currently preparing the European market launch of the Eyemate system and has started the US market FDA approval process. The company will build a strong business foundation on the sales of Eyemate biosensors and recurring revenues for remote patient monitoring and therapy guidance services.”

Investors value the MEDICA Innovation World Cup, a premier venue for companies that are transforming health care. Remote patient monitoring and telehealth are a key focus, as they are powering the transformation of chronic disease management, including the $6B glaucoma care market.